Petros G. Nikolinakos, MD, CPI (Certified Principal Investigator) is University Cancer & Blood Center’s managing partner. He also serves as the director and principal investigator of UCBC’s clinical research program, which conducts numerous trials involving novel targeted therapies, immunotherapies and breakthrough cancer treatments. Dr. Nikolinakos is a clinical Associate Professor at the University of Georgia and Augusta University and is a recipient of the 2013 ASCO Clinical Trials Participation Award.
Dr. Nikolinakos is board certified in medical oncology, hematology and internal medicine. He joined UCBC in September 2009 after completing fellowship in Hematology and Oncology at the NCI designated MD Anderson Cancer Center in Houston, Texas where he conducted basic science as well as clinical and translational research. Prior to this, he was a resident and Chief Medical Resident at Chicago’s Cook County Hospital.
An author and cancer researcher, Dr. Nikolinakos has published on a variety of clinical and basic science cancer topics in The New England Journal of Medicine, Journal of Cancer Research, Journal of Clinical Oncology, Oncogene, American Journal of Hematology, Journal of Clinical Investigation, Public Library of Science, and the Journal of Thoracic Oncology. His numerous abstracts have been presented at the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).